Enanta Pharmaceuticals Inc (ENTA)
5.70
-0.16
(-2.73%)
USD |
NASDAQ |
Mar 28, 16:00
5.70
0.00 (0.00%)
After-Hours: 20:00
Enanta Pharmaceuticals Max Drawdown (5Y): 95.05% for Feb. 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 54.78% |
| Recursion Pharmaceuticals Inc | -- |
| Moderna Inc | 93.70% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.60% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -40.69 |
| Beta (5Y) | 0.4778 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 60.54% |
| Historical Sharpe Ratio (5Y) | -0.5593 |
| Historical Sortino (5Y) | -0.9724 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.99% |